Of the remaining studies which used the seven-point Likert scale to determine change in dyspnoea status, EVEREST, REVIVE and ASCEND-HF showed improvement (although this did not reach statistical significance in ASCEND-HF).
← all excerpts
What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?
1
—
—